Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Is my MS patient failing treatment?
Brain structural connectivity in late-life major depressive disorder.
Comparison of myelin water fraction values in periventricular white matter lesions between MS and NMOSD.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
3D-DIR for early differential diagnostic and prognostic evaluation of NMO.
Major depressive disorder.
Time and brain health both matter in multiple sclerosis.
The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple Sclerosis.
Influence of a low dose of silver nanoparticles on cerebral myelin and behavior of adult rats.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists.
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
Subcellular Optogenetic Stimulation for Activity-Dependent Myelination of Axons in a Novel Microfluidic Compartmentalized Platform.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial.
Poster 347 Physical Therapy Utilization in the Management of Multiple Sclerosis in the United States.
Poster 200 Demyelinating Polyneuropathy Post-Operatively in a Patient with Squamous Cell Carcinoma of the Tongue: A Case Report.
Reorganization of Lipid Diffusion by Myelin Basic Protein as Revealed by STED Nanoscopy.
Walking impairs cognitive performance among people with multiple sclerosis but not controls.
Individual Differences in the Alignment of Structural and Functional Markers of the V5/MT Complex in Primates.
TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.
Causality Analysis of Inertial Body Sensors for Multiple Sclerosis Diagnostic Enhancement.
Neuroimmunological Implications of AQP4 in Astrocytes.
The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis.
Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
Pages
« first
‹ previous
…
787
788
789
790
791
792
793
794
795
…
next ›
last »